Entries of Weller, M. on the publication server
 | Up a level |
Number of items: 3.
2011
Weller, M., Gorlia, T., Cairncross, J. G., van den Bent, M. J. 
, Mason, W., Belanger, K., Brandes, A. A. , Bogdahn, Ulrich, Macdonald, D. R., Forsyth, P., Rossetti, A. O. , Lacombe, D., Mirimanoff, R.-O., Vecht, C. J. and Stupp, R.
(2011)
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.
Neurology 77 (12), pp. 1156-1164.
Fulltext not available.
, Mason, W., Belanger, K., Brandes, A. A. , Bogdahn, Ulrich, Macdonald, D. R., Forsyth, P., Rossetti, A. O. , Lacombe, D., Mirimanoff, R.-O., Vecht, C. J. and Stupp, R.
(2011)
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.
Neurology 77 (12), pp. 1156-1164.
Fulltext not available.
2008
Dresemann, G., Hosius, C., Lilienthal, J., Schleyer, E., Bogdan, U., Weller, M. and Paulus, W.
(2008)
Treatment failure due to intracerebral stem cell-like behavior of glioblastoma (GBM) cells: A reason for targeted maintenance therapy with imatinib (I) and hydroxyurea (H)? An analysis of study DE21 and DE40 (Ambrosia).
Journal of Clinical Oncology 26 (15_sup), p. 2048.
Fulltext not available.
2005
Herrlinger, Ulrich, Steinbrecher, A., Rieger, J., Hau, Peter, Kortmann, R.-D., Meyermann, R., Schabet, M., Bamberg, M., Dichgans, J., Bogdahn, U. and Weller, M.
(2005)
Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
Journal of neurology 252 (3), pp. 291-299.
Fulltext not available.